BNTX

BioNTech SE

Price

chg

chg neg

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

low api

52 wk hi

high api

Cash

$6.82B

Burn Rate (Qtr)

NA

Mkt Cap

mkt cap api

Avg Volume

volume api

*cash/burn updated:

Q1 '22

Drug Pipeline

Click on drug name or indication to see upcoming trial info, prior data, and more general information.

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Loading Catalysts...

search in progress

Pipeline powered by

BNTX

BPIQ_Logo_RGB-01.jpg

Company Profile

We are a next generation immunotherapy powerhouse pioneering individualized immunotherapies

Recent Posts

See what the community is saying - click to see full post.

Is Booster in China a Big Opp for Covid Vaccine Companies?

Smid-Cap Covid Vaccine update

All Covid Vaccines May Have the Rare Blood-Clotting Side Effect

BNTX & PFE - Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine

BNTX & PFE - Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints

Pfizer and BioNTech COVID-19 Vaccine (BNT-162) proves more than 90% effective